Cite
A bimetallic nanoplatform for STING activation and CRISPR/Cas mediated depletion of the methionine transporter in cancer cells restores anti-tumor immune responses.
MLA
Huang, Ying, et al. “A Bimetallic Nanoplatform for STING Activation and CRISPR/Cas Mediated Depletion of the Methionine Transporter in Cancer Cells Restores Anti-Tumor Immune Responses.” Nature Communications, vol. 14, no. 1, Aug. 2023, pp. 1–15. EBSCOhost, https://doi.org/10.1038/s41467-023-40345-3.
APA
Huang, Y., Qin, G., Cui, T., Zhao, C., Ren, J., & Qu, X. (2023). A bimetallic nanoplatform for STING activation and CRISPR/Cas mediated depletion of the methionine transporter in cancer cells restores anti-tumor immune responses. Nature Communications, 14(1), 1–15. https://doi.org/10.1038/s41467-023-40345-3
Chicago
Huang, Ying, Geng Qin, TingTing Cui, Chuanqi Zhao, Jinsong Ren, and Xiaogang Qu. 2023. “A Bimetallic Nanoplatform for STING Activation and CRISPR/Cas Mediated Depletion of the Methionine Transporter in Cancer Cells Restores Anti-Tumor Immune Responses.” Nature Communications 14 (1): 1–15. doi:10.1038/s41467-023-40345-3.